Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Passage Bio, Inc. - Common Stock (NQ:PASG)

9.200 -0.310 (-3.26%)
Streaming Delayed Price Updated: 1:47 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Passage Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Expert Ratings for Passage Bio ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday! 
Via InvestorPlace
News headline image
Passage Bio Stock Jumps After Gene Therapy Study In Lysosomal Storage Disorder ↗
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio: Q1 Earnings Insights ↗
Passage Bio (NASDAQ:PASG) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Earnings Scheduled For May 16, 2022 ↗
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
News headline image
Passage Bio Reports Third Quarter 2022 Financial Results and Provides Business Updates
From Passage Bio
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Passage Bio to Present at Guggenheim 4th Annual Immunology & Neurology Day
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio To Cut Workforce, Prioritize R&D Programs To Reduce Operating Expenses ↗
Passage Bio Inc (NASDAQ: PASG) will  
Via Benzinga
News headline image
Passage Bio: Q4 Earnings Insights ↗
Passage Bio (NASDAQ:PASG) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
Passage Bio to Report Third Quarter 2022 Financial Results on November 10, 2022
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Announces Appointment of William Chou, M.D. as Chief Executive Officer
From Passage Bio
Via GlobeNewswire
News headline image
Newman Ferrara LLP Announces Corporate Governance Investigations of Passage Bio, Inc. (PASG)
From Newman Ferrara LLP
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
  
Via Benzinga
News headline image
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Passage Bio Commences Initial-Stage Brain Disorder Study ↗
Passage Bio (NASDAQ: PASG) has dosed the first patient in the global Phase 1/2 upliFT-D clinical trial evaluating PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin... 
Via Benzinga
News headline image
Preview: Passage Bio's Earnings ↗
Passage Bio (NASDAQ:PASG) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Passage Bio... 
Via Benzinga
News headline image
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. 
Via Benzinga
News headline image
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday ↗
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. 
Via Benzinga
News headline image
Passage Bio to Report Second Quarter 2022 Financial Results on August 4, 2022
From Passage Bio
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million. 
Via Benzinga
News headline image
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More ↗
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from... 
Via Benzinga
News headline image
2 Stocks Under $3 Insiders Are Aggressively Buying ↗
US crude oil futures traded higher on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
Via Benzinga
Rising Number of Mental Health Disorders Fuel Advancing Initiatives to Reduce Psychiatric and Neurological Conditions
Palm Beach, FL –– March 8, 2022 – FinancialNewsMedia.com News Commentary – According to a report from Grand View Research “High unmet medical needs and government initiatives to reduce the psychiatric... 
Via FinancialNewsMedia
Topics Economy
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.